PROVIDER PROFILE · NPI 1407836224
Mark RawsonM.D.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,451
Beneficiaries
—
Total drug cost
$61K
Distinct drugs
48
Brand share
17.0%
Top prescribed drugs
Levothyroxine Sodium105 claims
Furosemide98 claims
Metoprolol Succinate82 claims
Rivaroxaban71 claims
Metformin Hcl51 claims
QUALITY · MIPS · 2024
Final MIPS score
85.5
Quality
81.0
Cost
70.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.44%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mark Rawson's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| SANFORD HEALTH NETWORK | 11 | 18 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE